Thursday, February 27, 2020

Financial News Conference Full Year 2019 Results

Location: Leverkusen, Baykomm (Bayer‘s Communication Center)

Bayer strategically and operationally successful

Group sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros
EBITDA before special items increases by 28.3 percent to 11.503 billion euros
Core earnings per share up by 14.3 percent to 6.40 euros
Net income rises 141.4 percent to 4.091 billion euros – gain of 1.637 billion euros on sale of Currenta stake
Free cash flow of 4.214 billion euros above expectations
Proposed dividend of 2.80 euros per share
Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business
Pharmaceuticals shows encouraging business development
Sales growth at Consumer Health, earnings at prior-year level despite divestments
Ongoing portfolio, structural and efficiency measures implemented successfully
Glyphosate’s positive safety profile confirmed – appeal and mediation proceedings moving forward
Outlook for 2020: increase in sales, earnings and free cash flow
Ambitious sustainability targets set